Scope of the Study
A biosensor is a measuring system which converts a biological response into an electrical signal. It is extensively used in clinical applications for diagnosis of diabetes mellitus. It mostly includes a probe along with a sensitive biological detecting material. The mounting demand for biosensors in industries for instance healthcare, biodefense, environmental monitoring, and food & beverages worldwide is likely to be a prime driver for the global biosensors market.
The market study is being classified, by Application (Point-Of-Care, Home Diagnostics, Research Labs, Security & Biodefense, Environmental Monitoring, Food & Beverage Industry and Others) and major geographies with country level break-up. According to AMA, the Global Biosensors market is expected to see growth rate of 9.2%
Abbott Point of Care Inc. (United States), Medtronic, Inc. (United States), F. Hoffman-La Roche Ltd. (Switzerland), Siemens AG (Germany), LifeScan, Inc. (United States), LifeSensors Inc. (United States), Nova Biomedical Corp. (United States), Acon Laboratories Inc. (United States), Universal Biosensors (Australia) and Pharmaco-Kinesis Corporation (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Bayer Healthcare AG (Germany), Biacore (United Kingdom), Bio-Rad Laboratories Inc. (United States), Biosensors International Ltd. (Singapore), Ercon, Inc. (United States), DuPont (United States), Sysmex Corporation (Japan), M-Biotech, Neurosky, Inc. (United States), Qtl Biosystems, LLC (United States), Molecular Devices Corp. (United States) and Draeger Safety (United States).
Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Biosensors market throughout the predicted period.
AdvanceMarketAnalytics has segmented the market of Global Biosensors market by Type, Application and Region.
On the basis of geography, the market of Biosensors has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Type, the sub-segment i.e. Electrochemical Biosensors will boost the Biosensors market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Products, the sub-segment i.e. Wearable Biosensors will boost the Biosensors market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Technology, the sub-segment i.e. Electrochemical Biosensors will boost the Biosensors market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Emergence of Nanotechnology-Based Biosensors
- Significant Technological Advancements in the Past Few Years
- Increasing Use of Biosensors to Monitor Glucose Levels in Individuals with Diabetes
- Increased Demand for Home-Based POC Devices
- Technological Advancements in Biosensors Technology
- Growing Demand for Glucose Monitoring in Diabetic Patients
- The problem regarding the Slow Rate of Commercialization and High Costs Involved in Research and Development
- Reluctance toward the Adoption of New Treatment Practices
- Emerging Market in Developing Countries
- High-Growth Opportunities in Environmental Monitoring, Biodefense, and the Food Industry
- Rising Demand from Emerging Economics Such as China and India
- Government Regulations regarding Long Certification and Approval Cycles
- Issue related to Pricing Pressure in the POC Market
Market Leaders and their expansionary development strategies
The market is fragmented with numerous players focusing on technique and quality of the product due to which the global biosensors market can witness an upsurge in the forecast period
In February 2016, the Johnson & Johnson (United States) Company has launched Onetouch Verio flex blood glucose monitoring system with ColorSure technology. Hence, it will benefit increase the product portfolio of the company
Key Target AudienceBiosensors Service Providers, Manufacturing Companies, Research Organizations, Ballast Water Treatment-Related Associations, Organizations, Forums, and Alliances, Distributors, Resellers, and Traders, Government Bodies Such As Regulating Authorities and Policy Makers and Venture Capitalists, Private Equity Firms, and Startup Companies
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase